Phenomix Sciences

📍 St Paul, United States🗓 Founded 2021👥 10 employees💰 Last funded 2018
Biotechnology Research🌐 phenomixsciences.com
Website LinkedIn
Phenomix Sciences is a precision medicine obesity biotechnology pioneer on a mission to conquer obesity globally through the science of phenotyping, the understanding of how genes combined with environmental and behavioral factors can inform obesity treatment plans. Mayo Clinic physicians, scientists, and researchers, Drs. Acosta and Camilleri, founded the company under the belief that the key to understanding obesity is unprecedented access to its clinical and molecular information throughout all stages and phenotypes of the disease. Phenomix leverages data intelligence to yield better accuracy in predicting individual patient response to specific weight loss interventions and reducing the variability in weight loss results for patients.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Phenomix Sciences?
Phenomix Sciences has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Phenomix Sciences last raise funding?
The most recent investment in Phenomix Sciences recorded on gritt.io was in 2018.
When was Phenomix Sciences founded?
Phenomix Sciences was founded in 2021.
What industry is Phenomix Sciences in?
Phenomix Sciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Phenomix Sciences based?
Phenomix Sciences is headquartered in St Paul, United States.